Wed, Apr 23, 2014, 1:20 PM EDT - U.S. Markets close in 2 hrs 40 mins

Recent

% | $
Quotes you view appear here for quick access.

Vertex Pharmaceuticals Incorporated Message Board

swhitemd50 1 post  |  Last Activity: Mar 31, 2014 11:25 AM Member since: Jul 4, 2011
  • Reply to

    Form DEF 14 A

    by rojospan Mar 30, 2014 2:46 PM
    swhitemd50 swhitemd50 Mar 31, 2014 11:25 AM Flag

    Qdelphan:
    I have trouble believing they can charge 250K for the VX809/770 combo. If the phase 3 trials match the phase 2, there will be moderate improvement. How much can be charged for moderate improvement in 28000 patients? It will not be the dramatic improvement seen in the 1100 patients for which Kalydeco mono therapy was initially approved. And when you have 28,000 patients instead of just 1100, it makes it even more difficult to justify a high price. I have a significant long position in this stock but I have my doubts.

VRTX
66.79-1.51(-2.21%)1:19 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.